China’s Growth Faces Structural Challenges Amid Doubts Over Data 
UOB Q1 Profit Meets Expectations as Loan Growth Offsets Lower Interest Rates 
Taiwan Activates Backup Communications After Undersea Cable Break on Dongyin Island 
AWS Data Center Overheating Disrupts Cloud Services in Northern Virginia 
AI-Driven Inflation Raises U.S. Consumer Prices, Goldman Sachs Says 
Orsted Q1 EBITDA Beats Expectations Despite U.S. Impairments 
Trump Invites Top CEOs Including Nvidia, Apple, Boeing to China Summit With Xi Jinping 
Morgan Stanley Bets on Optical Component Stocks in Greater China Tech Sector 
UK Markets Face Rising Volatility as Hedge Funds Target Pound and Gilts 
TikTok Nears $400 Million Settlement With Trump Administration Over Child Privacy Lawsuit 
Apple Q2 2026 Earnings Surge as iPhone 17 Sales Drive Record Revenue 
Hantavirus Cruise Ship Outbreak Triggers Global Health Alert 
Wall Street Rebounds as Investors Eye Tariff Uncertainty, Jobs Report 
U.S. Condemns China's Dominance in Global Shipbuilding and Maritime Sectors 
Broadcom Eyes $35 Billion AI Chip Financing Deal With Apollo and Blackstone 
Elliott Investment Management Takes Significant Stake in BP to Push for Value Growth 
Tempus AI Inc (NASDAQ:TEM) shares surged over 18% to $41.62 in after-hours trading following a disclosure by former House Speaker Nancy Pelosi. Pelosi revealed in a recent filing that she had purchased 50 call options on the artificial intelligence-focused precision medicine firm. The options, priced between $50,000 and $100,000, have a $20 strike price and expire on January 16, 2026.
Pelosi’s disclosure also included call options in tech giants Alphabet Inc (NASDAQ:GOOGL), NVIDIA Corporation (NASDAQ:NVDA), and Amazon.com Inc (NASDAQ:AMZN).
The rally comes despite Tempus being down about 12% since its public listing in June 2024. The stock faced pressure last week when a major shareholder sold $33.1 million worth of shares, even after Tempus reported strong 2024 earnings. However, the company flagged a slowdown in contract research organization revenues, sparking some investor caution.
Sentiment around Tempus has turned highly bullish on trading platforms like Stocktwits, with discussions about the stock spiking after Pelosi’s disclosure. The platform reported increased interest and optimism, which contributed to the stock’s strong rally.
Tempus leverages artificial intelligence technology for precision medicine applications, and its growth potential continues to attract attention from prominent investors. This latest move by Pelosi, a well-known and closely watched figure in the investment community, has added momentum to the stock, drawing increased scrutiny from retail and institutional investors alike.
As interest in AI and precision medicine grows, Tempus is positioned as a key player, gaining visibility and market attention.
